Recursion Announces Initiation of Phase 2/3 Trial for the Treatment of NF2-Mutated Meningiomas at Children's Tumor Foundation NF Conference

June 20, 2022
Written By:
No items found.
Read the post ›

Decoding biology to radically improve lives.®

Proud founding member of BioHive, the fastest growing life sciences community in the nation

Get In Touch

41 S Rio Grande Street
Salt Lake City, UT 84101
phone: (385) 269-0203
Investor Relations

Policies

Website Terms of Use
Privacy Policy
Vendor Expectations Manual & Resources
Accessibility

Connect

LinkedIn
X
Instagram
Youtube
Facebook
Bluesky